Walgreens Is in Talks to Sell Itself to Private-Equity Firm Sycamore Partners: WSJ

Walgreens is in particularly awful shape

Drug stores around the United States are struggling. Especially Walgreens.

Boots owner in talks over sale to private equity

Sycamore Partners, a US firm which owns the stationary brand Staples, said to be potential buyer

Walgreens could sell Boots

Walgreens Boots Alliance (WBA), owner of Boots the Chemist, is said to be in talks centring on a possible Sycamore Partners takeover. Sycamore, which formerly held a stake in the UK shoe and handbag brand Kurt Geiger, has also made several unsuccessful bids for the Ted Baker fashion label in the past. A deal with the US private equity giant could put a $10 billion (€9.5 billion) price on WBA… Source

Walgreens could 'aggressively' cut costs if privately owned, analyst says

If Walgreens Boots Alliance Inc. is bought by private equity firm Sycamore Partners, it would have more flexibility to "aggressively" reduce costs in order to address persisting industry challenges, according to an industry analyst. "As a private company, WBA [Walgreens Boots Alliance] would have more flexibility to make major changes to the business, in our view, and aggressively cut costs to try to tackle recent challenges with pharmacy operat…

Walgreens Stock Falls Over 3% In Premarket As Wall Street Veterans Debate Private Equity Deal Value Amid Sycamore Takeover Talks - Walgreens Boots Alliance (NASDAQ:WBA)

Walgreens Boots Alliance Inc. (NASDAQ:WBA) retreated 3.26% to $10.08 in Wednesday’s pre-market trading, following Tuesday’s 20% surge, as prominent market voices weighed in on the potential private takeover by Sycamore Partners. What Happened: Gary Black, Managing Partner at The Future Fund LLC, outlined a detailed valuation case for a possible $15 per share offer. Walgreens management guided for the fiscal year 2025, expecting adjusted earning…

Rumors about possible sale of Walgreens spark concerns about store, pharmacy closures

Rumors about possible sale of Walgreens spark concerns about closures